相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical review
Elisabeth Luporsi et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Comparison of Visual and automated assessment of Ki-67 proliferative activity and their impact on outcome in primary operable invasive ductal breast cancer
Z. M. A. Mohammed et al.
BRITISH JOURNAL OF CANCER (2012)
How Reliable Is Ki-67 Immunohistochemistry in Grade 2 Breast Carcinomas? A QA Study of the Swiss Working Group of Breast- and Gynecopathologists
Zsuzsanna Varga et al.
PLOS ONE (2012)
Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment
Peter A. Fasching et al.
BMC CANCER (2011)
Ki67 proliferation in core biopsies versus surgical samples - a model for neo-adjuvant breast cancer studies
Quinci Romero et al.
BMC CANCER (2011)
MIB1/Ki-67 labelling index can classify grade 2 breast cancer into two clinically distinct subgroups
Mohammed A. Aleskandarany et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
St. Gallen 2011: Summary of the Consensus Discussion
Michael Gnant et al.
BREAST CARE (2011)
Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group
Mitch Dowsett et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Tumor Topoisomerase II Alpha Status and Response to Anthracycline-Based Neoadjuvant Chemotherapy in Breast Cancer
Aliz Nikolenyi et al.
ONCOLOGY (2011)
Advantages of adjuvant chemotherapy for patients with triple-negative breast cancer at Stage II: usefulness of prognostic markers E-cadherin and Ki67
Shinichiro Kashiwagi et al.
BREAST CANCER RESEARCH (2011)
Relationship between oestrogen receptor status and proliferation in predicting response and long-term outcome to neoadjuvant chemotherapy for breast cancer
Robin L. Jones et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Comparative validation of the SP6 antibody to Ki67 in breast cancer
Lila Zabaglo et al.
JOURNAL OF CLINICAL PATHOLOGY (2010)
Ki67 in breast cancer: prognostic and predictive potential
Rinat Yerushalmi et al.
LANCET ONCOLOGY (2010)
Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009
A. Goldhirsch et al.
ANNALS OF ONCOLOGY (2009)
Ki-67 Expression Gives Additional Prognostic Information on St. Gallen 2007 and Adjuvant! Online Risk Categories in Early Breast Cancer
So-Youn Jung et al.
ANNALS OF SURGICAL ONCOLOGY (2009)
Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
Maggie C. U. Cheang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Recent advances in systemic therapy New diagnostics and biological predictors of outcome in early breast cancer
Catherine Oakman et al.
BREAST CANCER RESEARCH (2009)
The relationship between the systemic inflammatory response, tumour proliferative activity, T-lymphocytic and macrophage infiltration, microvessel density and survival in patients with primary operable breast cancer
A. M. Al Murri et al.
BRITISH JOURNAL OF CANCER (2008)
Prognostic and Predictive Value of Centrally Reviewed Ki-67 Labeling Index in Postmenopausal Women With Endocrine-Responsive Breast Cancer: Results From Breast International Group Trial 1-98 Comparing Adjuvant Tamoxifen With Letrozole
Giuseppe Viale et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Predictive value of tumor Ki-67 expression in two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer
Giuseppe Viale et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Chromophore-assisted light inactivation of pKi-67 leads to inhibition of ribosomal RNA synthesis
R. Rahmanzadeh et al.
CELL PROLIFERATION (2007)
Measuring proliferation in breast cancer: practicalities and applications
Mark J. Beresford et al.
BREAST CANCER RESEARCH (2006)
Correlation between MIB-1 and other proliferation markers -: Clinical implications of the MIB-1 cutoff value
F Spyratos et al.
CANCER (2002)
The prognostic value of proliferation indices: a study with in vivo bromodeoxyuridine and Ki-67
III Goodson WH et al.
BREAST CANCER RESEARCH AND TREATMENT (2000)
分享论文
